[1] |
Bradley PJ. Adenoid cystic carcinoma evaluation and management: progress with optimism[J]. Curr Opin Otolaryngol Head Neck Surg, 2017, 25(2): 147-153.
|
[2] |
Von Holstein SL, Rasmussen PK, Heegaard S. Tumors of the lacrimal gland[J]. Semin Diagn Pathol, 2016, 33(3): 156-163.
|
[3] |
Nagao T. "Dedifferentiation" and high-grade transformation in salivary gland carcinomas[J]. Head Neck Pathol, 2013, 7: S37-S47.
|
[4] |
Zhou Q, Chang H, Han YD, et al. High-grade transformation in adenoid cystic carcinoma: a clinicopathologic study[J]. Zhonghua Bing Li Xue Za Zhi, 2013, 42(2):106-110.
|
[5] |
EI-Naggar AK, Chan JK, Grandis JR, et al. WHO classification of head and neck tumors[M]. Lyon: IARC Press, 2017: 164-165.
|
[6] |
Szanto PA, Luna MA, Tortoledo ME, et al. Histologic grading of adenoid cystic carcinoma of the salivary glands[J]. Cancer, 1984, 54: 1062-1069.
|
[7] |
Andrés CP, Juan PR, Patrick JB, et al. Adenoid cystic carcinoma of the head and neck - An update[J]. Oral Oncol, 2015, 51(7): 652-661.
|
[8] |
Sanders JC, Mendenhall WM, Weming JW. Adenoid cystic carcinoma of the lacrimal gland[J].Am J Otolaryngol, 2016, 37(2): 144-147.
|
[9] |
Falcone MM, Tran KD, avakoli M, et al. Adenoid cystic carcinoma of the lacrimal gland in a 14-year-old male[J]. Orbit, 2017, 36(6): 448-451.
|
[10] |
Friedrich RE, Bleckmann V. Adenoid cystic carcinoma of salivary and lacrimal gland origin: localization, classification, clinical pathological correlation, treatment results and long-term follow-up control in 84 patients[J]. Anticancer Res, 2003, 23(2A): 931-940.
|
[11] |
Zhang M, Fathy C, Breazzano MP, et al. Intra-arterial chemotherapy for lacrimal gland adenoid cystic carcinoma[J]. International ophthalmology clinics, 2017, 51(3): 143-152.
|
[12] |
Barnes EL, Eveson JW, Reichart P, et al, eds. Head and Neck Tumours[M]. Lyon: IARC Press, 2005:221-222.
|
[13] |
Costa AF, Altemani A, Hermsen M. Current concepts on dedifferention/high-grade transformation in salivary gland tumors[J]. Patholog Res Int, 2011: 325965.
|
[14] |
Han J, Kim YD, Woo KI, et al. Long-term outcomes of eye-sparing surgery for adenoid cystic carcinoma of lacrimal gland[J]. Ophthal Plast Reconstr Surg, 2018, 34(1): 74-78.
|
[15] |
Argyris PP, Pambuccian SE, Cayci Z, et al. Lacrimal gland adenoid cystic carcinoma with high-grade transformation to myoepithelial carcinoma: report of a case and review of literature[J]. Head Neck Pathol, 2013, 7(1): 85-92.
|
[16] |
Seethala RR, Hunt JL, Baloch ZW, et al. Adenoid cystic carcinoma with high-grade transformation: a report of 11 cases and a review of the literature[J]. Am J Surg Pathol, 2007, 31(11): 1683-1694.
|
[17] |
Miyazaki M, Aoki M, Koga K, et al. Adenoid cystic carcinoma with high-grade transformation forming spindle cell component of the submandibular gland[J]. Auris Nasus Larynx, 2019, 46(6): 934-939.
|
[18] |
North JP, McCalmont TH, Fehr A, et al. Detection of MYB alterations and other immunohistochemical markers in primary cutaneous adenoid cystic carcinoma[J]. Am J Surg Pathol, 2015, 39(10): 1347-1356.
|
[19] |
Emanuel P, Wang B, Wu M, et al. p63 immunohistochemistry in the distinction of adenoid cystic carcinoma from basaloid squamous cell carcinoma[J]. Mod Pathol, 2005, 18(5): 645-650.
|
[20] |
Sato K, Ueda Y, Sakural A, et al. Adenoid cystic carcinoma of the maxillary sinus with gradual histologic transformation to high-grade adenocarcinoma: a comparative report with dedifferentiated carcinoma[J]. Virchows Arch, 2006, 448(2): 204-208.
|
[21] |
Von Holstein SL, Fehr A, Pers M, et al. Adenoid cystic carcinoma of the lacrimal gland: MYB gene activation, genomic imbalances, and clinical characteristics[J]. Ophthalmology, 2013, 120 (10): 2130-2138.
|
[22] |
Malhotra KP, Agrawal V, Pandey R. High grade transformation in adenoid cystic carcinoma of the parotid: report of a case with cytologic, histologic and immunohistochemical study[J]. Head Neck Pathol, 2009, 3(4): 310-314.
|
[23] |
Xie J, Lin LS, Huang XY, et al. The NOTCH1-HEY1 pathway regulates self-renewal and epithelial-mesenchymal transition of salivary adenoid cystic carcinoma cells[J]. Int J Biol Sci, 2020, 16(4): 598-610.
|
[24] |
Seethala RR, Cieply K, Barnes EL, et al. Progressive genetic alterations of adenoid cystic carcinoma with high-grade transformation[J]. Arch Pathol Lab Med, 2011, 135(1): 123-130.
|
[25] |
Seethala RR.Histologic grading and prognostic biomarkers in salivary gland carcinomas[J].Adv Anat Pathol, 2011, 18(1): 29-45.
|
[26] |
Pusztaszeri MP, Sadow PM, Ushiku A, et al. MYB immuno-staining is a useful ancillary test for distinguishing adenoid cystic carcinoma from pleomorphic adenoma in fine-needle aspiration biopsy specimens[J]. Cancer Cytopathol, 2014, 122(4): 257-265.
|
[27] |
Chen TY, Keeney MG, Chintakuntlawar AV, et al. Adenoid cystic carcinoma of the lacrimal gland is frequently characterized by MYB rearrangement[J]. Eye (Lond), 2017, 31(5): 720-725.
|
[28] |
刘尧,刘月平. WHO(2017)涎腺肿瘤分类解读[J]. 临床与实验病理学杂志,2018,34(1): 1-3.
|
[29] |
Serocki M, Bartoszewska S, Janaszak-Jasiecka A, et al. miRNAs regulate the HIF switch during hypoxia: a novel therapeutic target[J]. Angiogenesis, 2018, 21(2): 183-202.
|
[30] |
Hao J, Jin X, Shi Y, et al. miR-93-5p enhance lacrimal gland adenoid cystic carcinoma cell tumorigenesis by targeting BRMS1L[J]. Cancer Cell Int, 2018, 18(1): 72-84.
|
[31] |
Zhang MX, Zhang J, Zhang H, et al. miR-24-3p suppresses malignant behavior of lacrimal adenoid cystic carcinoma by targeting PRKCH to Regulate p53/p21 Pathway[J]. PLoS One, 2016, 11(6): e0158433.
|